Immunological series

Immunization , Vaccines and Biologicals The Immunological Basis for Immunization Series Module 5 : Tuberculosis

Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.

European mistletoe (Viscum album) has been used in complementary cancer treatment, but little is known concerning its effects on immunological parameters, although there is evidence that Viscum may stimulate the immune system. In this study, a trial was conducted with cancer patients to determine whether Viscum album extracts could improve the results of immune tests. These were: white blood ce...

The Immunological Basis for Immunization Series Module 9 : Haemophilus influenzae type b

Haemophilus influenzae type b vaccines. (Immunological basis for immunization series ; module 9) 1.Influenza, human-prevention and control. 2.Influenza vaccines-therapeutic use. 3.Influenza B virus-drug effect. e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, a...

IVB The immunological basis for immunization series Module 3 : Tetanus Update 2006

(Immunological basis for immunization series ; module 3) «This module is a revision of Artur Galazka's 1st edition (WHO/EPI/GEN/93.13) … ". 1.Tetanus-immunology. 2.Tetanus toxoid-immunology. e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address ...

Childhood bullous pemphigoid: clinical and immunological findings in a series of 4 cases.

BACKGROUND Bullous pemphigoid (BP) is an autoimmune blistering disease that is rare in childhood. As in adult BP, antibodies against the 180-kDa antigen (BP180) seem to be involved in the pathogenesis of the disease, but, to date, only a small number of children with the disease have been examined immunologically. OBSERVATIONS We report the cases of 4 infants with BP aged 5 to 12 months. All ...